Ticagrelor Improves Peripheral Arterial Function in Acute Coronary Syndrome Patients: Relationship With Adenosine Plasma Level. - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Journal of the American College of Cardiology Année : 2016

Ticagrelor Improves Peripheral Arterial Function in Acute Coronary Syndrome Patients: Relationship With Adenosine Plasma Level.

Résumé

Ticagrelor, a P2Y12 receptor antagonist, significantly reduces the incidence of major cardiovascular events in acute coronary syndrome (ACS) compared with standard treatment with clopidogrel (1). It has been suggested that this benefit effect may be accounted for by its pleiotropic properties via a purinergic mechanism. Indeed, ticagrelor increases the endogenous adenosine plasma level (APL) via red blood cell uptake inhibition in primary ACS patients compared with clopidogrel (2). However, the link between these “pleiotropic” properties and the improvement in microvascular dysfunction (MiD) remains poorly investigated. This study aimed to determine whether the increase in APL achieved with ticagrelor might improve endothelial dysfunction in primary ACS patients.
Fichier principal
Vignette du fichier
C_7_Ticagrelor_Improves_Peripheral_Arterial_Function_in_Acute_Coronary_Syndrome_Patients_v.pdf (159.92 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01311749 , version 1 (18-10-2016)

Identifiants

Citer

Julien Fromonot, Francoise Dignat-George, Pascal Rossi, Giovanna Mottola, Nathalie Kipson, et al.. Ticagrelor Improves Peripheral Arterial Function in Acute Coronary Syndrome Patients: Relationship With Adenosine Plasma Level.. Journal of the American College of Cardiology, 2016, 67 (16), pp.1967-1968. ⟨10.1016/j.jacc.2016.02.023⟩. ⟨hal-01311749⟩
70 Consultations
167 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More